Revascularization Techniques in Pediatric Cerebrovascular Disorders

Published on 13/03/2015 by admin

Filed under Neurosurgery

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1238 times

Chapter 61 Revascularization Techniques in Pediatric Cerebrovascular Disorders

This chapter focuses on methods used to revascularize the brain in the setting of treating pediatric cerebrovascular disease. While there are many situations that might require some form of surgical revascularization, there are three conditions in particular—atherosclerotic carotid disease, intracranial aneurysms, and moyamoya syndrome—that are most commonly encountered by neurosurgeons. However, age-specific differences in disease presentation mean that the spectrum of cerebrovascular disease encountered by neurosurgeons who treat children is notably different than what is seen in adult patients. Atherosclerotic carotid disease is not present in the pediatric population and using revascularization techniques to treat the rare pediatric intracranial aneurysm is rarely feasible. Since these conditions are rare in children, the use of revascularization techniques in these diagnoses will not be discussed here and the reader is referred to the relevant descriptions elsewhere in this textbook. This chapter will thus primarily center on the surgical revascularization of children with moyamoya syndrome.

Moyamoya Syndrome

Moyamoya syndrome is an arteriopathy characterized by progressive stenosis of the distal internal carotid arteries as they enter the cranial vault.1,2 With narrowing of the internal carotids, cerebral blood flow is reduced, cerebral ischemia develops, and collateral blood vessels develop in the region of the carotid bifurcation, on the cortical surface, and from branches of the external carotid artery (ECA). This alternative blood supply—comprised of maximally dilated pre-existing arteries and growth of new vessels—provides circulation to the region formerly supplied by the internal carotids. Although usually limited to the anterior circulation, this process may involve the posterior circulation as well; including the basilar and posterior cerebral arteries. The appearance of this basal collateral network on angiography has been compared to a hazy cloud or puff of smoke: the disease defined by the Japanese word “moyamoya.” Because of the natural propensity in patients with moyamoya for collateral vessels to the brain to develop from branches of the external carotid and because these arteries and those on the surface of the brain are not involved by the moyamoya arteriopathy, most of the surgical revascularization techniques in this condition utilize the external carotid circulation as a donor source of new blood flow to the ischemic brain.

Surgical Treatment of Moyamoya

Two general methods are employed: direct and indirect. In direct revascularization, a branch of the ECA (usually the superficial temporal artery [STA]) is anastomosed end to side to a cortical artery (usually a distal branch of the middle cerebral artery [MCA]), the so-called “STA-MCA bypass.” In contrast, indirect techniques involve mobilizing vascularized tissue supplied by the ECA (dura, muscle, pedicles of the STA) and placing it in contact with the brain to promote in-growth of new vessels to the cortex.

Historically, direct procedures have been used in adults, with immediate increase of blood flow to the ischemic brain cited as a major benefit of the procedure. Augmentation of cerebral blood flow usually does not occur for several weeks with indirect techniques. However, direct bypass is often technically difficult to perform in children because of the small size of donor and recipient vessels; making indirect techniques appealing. Nonetheless, direct operations have been successful in children as have indirect procedures in adults.35 Considerable debate exists regarding the relative merits and shortcomings of the two approaches; in fact, some centers advocate combinations of both approaches.57

Numerous indirect revascularization procedures have been described: encephaloduroarteriosynangiosis (EDAS) whereby the STA is dissected free over a course of several inches and then sutured to the cut edges of the opened dura; encephalomyosynangiosis (EMS) in which the temporalis muscle is dissected and placed onto the surface of the brain to encourage collateral vessel development; the combination of both, encephalo-myo-arterio-synangiosis (EMAS), a variant of EDAS in which the STA is sutured to the brain; pial synangiosis, described in detail below; and the drilling of multiple burr holes without vessel synangiosis.814 Dural inversion, carrying out a craniotomy, opening the dura, and turning the dural flaps inward over the surface of the brain has also been described as a revascularization technique.13 Cervical sympathectomy and omental transposition or omental pedicle grafting have also been described.2 We have found the technique of pial synangiosis particularly effective in the pediatric moyamoya population, and in a review of 143 patients treated with pial synangiosis, demonstrated marked reductions in stroke frequency following surgery.14 Regardless of the revascularization procedure utilized, the perioperative strategies for complication avoidance are relevant to all moyamoya patients, regardless of surgical technique employed.

Pial Synangiosis

We have recently published a specific perioperative protocol for patients with moyamoya15 (Table 61-1). This protocol has been adapted from our practice for all patients with moyamoya and highlights general strategies we have found useful in the surgical management of this condition.

Table 61-1 Perioperative Management Protocol Used at Our Institution for Patients with Moyamoya

At 1 Day Before Surgery
Continue aspirin therapy (usually 81 mg once a day orally if <70 kg, 325 mg once a day orally if ≥70 kg).
Admit patient to hospital for overnight intravenous hydration (isotonic fluids 1.25–1.5 × maintenance).
At Induction of Anesthesia
Institute electroencephalographic monitoring.
Maintain normotension during induction; also normothermia (especially with smaller children), normocarbia (avoid hyperventilation to minimize cerebral vasoconstriction, pCO2 > 35 mm Hg), and normal pH.
Placement of additional intravenous lines, arterial line, Foley catheter, and pulse oximeter.
Place precordial Doppler to monitor for venous air emboli (relevant with thicker bone resulting from extramedullary hematopoiesis).
During Surgery
Maintain normotension, normocarbia, normal pH, adequate oxygenation, normothermia, and adequate hydration.
Electroencephalographic slowing may respond to incremental blood pressure increases or other maneuvers to improve cerebral blood flow.
Postoperatively
Avoid hyperventilation (relevant with crying in children); pain control is important.
Maintain aspirin therapy on postoperative day 1.
Maintain intravenous hydration at 1.25–1.5 × maintenance until child is fully recovered and drinking well (usually 48–72 hours).

Revised from Smith ER, McClain CD, Heeney M, et al. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus. 2009;26:E10.

Preoperative Strategy and Imaging

Preoperative management of moyamoya patients is critical to the success of surgery. Strategy is based on the utilization of appropriate imaging for planning and the maintenance of hypervolemia, normocarbia, and prevention of thrombosis. A full five- or six-vessel (both ICAs, both ECAs, and one or both vertebrals as indicated) diagnostic angiogram is critical to the planning of the procedure for:

Once the decision to operate has been made, we follow a standardized perioperative protocol. Dehydration is a significant risk given the hypoperfused intracranial circulation. To minimize shifts in blood pressure during the induction of anesthesia, we routinely admit patients to the hospital on the evening prior to surgery for intravenous hydration. If there are no underlying cardiac or renal limitations, isotonic fluids are run at 1.5 times maintenance rate. Barring medical contraindication, patients are treated with daily aspirin therapy from the time of their diagnosis of moyamoya in order to minimize the risk of thrombosis in the slow-flowing cortical vessels. Dosing is continued up to and including the day prior to surgery (and restarted the day after surgery). Pain and anxiety must be aggressively managed, especially with children since hyperventilation, as occurs with crying, can induce cerebral vasoconstriction; leading to stroke. Steroids, cerebral dehydrating agents such as mannitol and anticonvulsants are not administered on a routine basis.

Operative Technique and Setup

In cases with bilateral disease, we will commonly treat both sides in a single operative sitting in order to reduce total anesthetic time (the anesthesia set-up time for a young child may take up to 1.5 hours if EEG electrodes are to be placed and if IV access is difficult, and having these already in place shortens the anesthesia time for the second side) and to limit the number of inductions and wake-ups; always a critical period for these compromised patients. We will usually treat the most affected side first, as determined either by clinical history or radiographic studies. If both sides are comparable in Suzuki grade and clinical status, then we will often treat the dominant hemisphere first.

The technique involves the following steps, which are described in more detail in following sections: (1) a scalp donor artery (most commonly, the parietal branch of the superficial temporal artery) is identified by Doppler and dissected, using a microscope from the very beginning of the dissection, from distal to proximal along with a cuff of galea and surrounding soft tissue; (2) the temporalis muscle is incised into four quadrants and retracted, and the largest possible craniotomy flap is turned in the available bony exposure; (3) the dura is opened into at least six flaps in order to increase the surface area of dura exposed to the pial surface and thereby enhance formation of collateral vessels from the dural vascular supply; (4) the arachnoid is opened widely over the surface of brain exposed by the dural opening; and (5) the intact donor artery is sutured directly to the pial surface using four to six interrupted 10-0 nylon sutures placed through the donor vessel adventitia and the underlying superficial pia. The bone flap is replaced over a Gelfoam cover of the dura, which is left widely open; the flap carefully secured to avoid compression of the donor artery. The temporal muscle and skin edges are carefully closed with absorbable sutures to similarly avoid compression of the donor vessel. The rationale behind the synangiosis procedure is that opening the arachnoid removes a barrier to the in-growth of new blood vessels into the brain and provides greater access of growth factors from the spinal fluid and brain to the donor vessel; the suturing of the donor vessel’s adventitia to the pial surface insures that the donor vessel will remain in contact with the brain in areas where the arachnoid has been cleared, again, to promote the rapid ingrowth of new blood supply to the underlying brain.

The specific equipment needed for the procedure includes:

The operating room is then set up in a standardized fashion. The EEG tech is in the room with EEG monitors available for viewing. The microscope set for an assistant on the right side of the surgeon (assuming a right-handed surgeon) and is draped and ready from the onset of the case. The scrub is also on the surgeon’s right. Immediate equipment is placed on mayo stands over the patient’s torso. The microscope is positioned with the base to the left of the surgeon. The anesthesia team is to the surgeon’s left or at the foot of the table.

The patient is then positioned. EEG electrodes are affixed in a standard array and the scalp is shaved over the expected course of the STA based on the angiogram. The parietal branch of the STA is mapped out using the Doppler probe and the skin is carefully marked with fine scratches from a sterile 22-gauge needle to outline its course from the distal end near the vertex to the root of the zygoma. The head is placed in pin fixation and the patient is positioned supine with the head turned parallel to the floor such that the STA site is level. Rolls are used as needed to reduce tension on the neck and the head is translated superior to the torso to facilitate venous drainage. The STA site is prepped; usually leaving the ear and face out of the field.

Operative Approach

Prior to incision, intravenous antibiotics are given. The microscope is employed from the onset of the case. No infiltration of the scalp with local anesthetic or epinephrine is used in order to avoid injury to the vessel.

Vessel Dissection

Using high magnification, a #15 blade is used to score the dermis at the distal end of the STA. A thin, curved pediatric hemostat and toothed Adson pickups are used by the surgeon (with suction and a second pickup by the assistant) to identify the STA under the skin. Using a repeated technique of subcutaneous dissection with the hemostat over the STA followed by elevation of the skin by the hemostat and an incision over the hemostat by the assistant, the STA is dissected along its length down to the root of the zygoma. Care must be taken to avoid tearing the vessel; particularly at tortuous bends or side branches. Irrigating bipolar (usually set at 25 with fine tips) is employed for hemostasis of small scalp vessels. A 0.05 × 3 cm Cottonoid is often useful to cover the exposed vessel to gently tamponade scalp bleeding as proximal dissection continues; electrocautery is used sparingly to control bleeding points along the incision line. A longer length of STA dissection is preferable (10 cm is optimal, although not always possible, especially in smaller children) (Fig. 61-1).

Following dissection of the STA branch, the “Colorado needle” electrocautery device (at low settings, usually one half to one third of the standard skin setting) is used in conjunction with the bipolar and microscissors to divide the galea and soft tissue on either side of the STA down to the temporalis fascia; leaving 1 to 2 mm of cuff on either side of the vessel. Two self-retaining retractors are then placed: one proximal and one distal. Dissection often terminates at the take-off of the frontal branch which should be preserved, if possible. However, if the bifurcation is high enough to prohibit mobilization of the STA then the frontal branch of the STA often must be divided. The preoperative arteriogram will indicate whether the frontal branch provides any significant intracerebral collaterals that can be relevant to the decision to potentially sacrifice the branch. Following the dissection of the vessel, a vessel loop is placed under the distal end of the STA and used to elevate the dissected portion of the vessel from the temporalis muscle. Monopolar electrocautery is then used to free up connective tissue around and beneath the vascular pedicle.

Complication Avoidance

The most significant postoperative complication in our series has been stroke, which in a series of 143 patients occurred at about 4% per operated hemisphere. Patients at the greatest risk appear to be those with neurologic instability around the time of surgery, those who have suffered a stroke within 1 month of the operation, or those with certain angiographic risk factors such as moyamoya disease in the posterior circulation. There have been two perioperative deaths related to ischemic stroke: one in a 5-year-old child operated on in the midst of a crescendo of strokes preoperatively and one in a 15-year-old boy with unusually fulminant disease with pre-existing basilar artery occlusion whose internal carotid artery—the sole supply of his posterior circulation—thrombosed following a unilateral operation. Other complications include four subdural hematomas requiring evacuation and two spinal fluid leaks.

Follow-Up

Careful follow-up of patients with moyamoya is warranted to monitor for disease progression and for response to therapy.16,17 We routinely obtain MRI and MRA studies 6 months after surgery. Postoperative angiograms are usually obtained 12 months after surgery and typically demonstrate excellent MCA collateralization from both the donor STA and the meningeal arteries. A repeat MRI and MRA is done for comparison purposes and for a new baseline. For high-risk patients, MRI/A may be obtained in lieu of an angiogram if contrast from the angiogram presents a substantial risk to the kidneys. Generally, annual MRIs are obtained in all patients for 3 to 5 years after the initial 1-year angiogram and then spaced out subsequent to the 5-year time point. Particular attention must be paid to patients with unilateral moyamoya as the opposite side can progress in up to one third of patients, especially in children.18 Patients are maintained on lifelong ASA therapy.

A review of 143 children with moyamoya syndrome treated with pial synangiosis had marked reductions in their stroke frequency after surgery especially after the first year postoperatively. In this group, 67% had strokes preoperatively and only 3.2% had strokes after at least 1 year of follow-up. The long-term results are excellent with a stroke rate of 4.3% (2 patients in 46) in patients with a minimum of 5 years of follow-up.19 This work supports the premise that pial synangiosis provides a significant protective effect against new strokes in this patient population.

Key References

Dauser R.C., Tuite G.F., McCluggage C.W. Dural inversion procedure for moyamoya disease. Technical note. J Neurosurg. 1997;86:719-723.

Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (“moyamoya” disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99(suppl 2):S238-S240.

Fung L.W., Thompson D., Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005;21:358-364.

Houkin K., Kamiyama H., Abe H., et al. Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke. 1996;27:1342-1346.

Houkin K., Kuroda S., Nakayama N. Cerebral revascularization for moyamoya disease in children. Neurosurg Clin North Am. 2001;12:575-584. ix

Ikezaki K. Rational approach to treatment of moyamoya disease in childhood. J Child Neurol. 2000;15:350-356.

Isono M., Ishii K., Kobayashi H., et al. Effects of indirect bypass surgery for occlusive cerebrovascular diseases in adults. J Clin Neurosci. 2002;9:644-647.

Kawaguchi S., Okuno S., Sakaki T. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg. 2000;93:397-401.

Matsushima T., Inoue T., Ikezaki K., et al. Multiple combined indirect procedure for the surgical treatment of children with moyamoya disease. A comparison with single indirect anastomosis with direct anastomosis. Neurosurgical Focus. 1998. 5:e4

Matsushima T., Inoue T., Katsuta T., et al. An indirect revascularization method in the surgical treatment of moyamoya disease—various kinds of indirect procedures and a multiple combined indirect procedure. Neurol Med Chir (Tokyo). 1998;38(suppl):297-302.

Scott R.M., Smith E.R. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226-1237.

Scott R.M., Smith J.L., Roberstson R.L. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg Spine. 2004;100:142-149.

Scott R.M., Smith J.L., Robertson R.L., et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004;100:142-149.

Sencer S., Poyanli A., Kiris T., et al. Recent experience with moyamoya disease in Turkey. Eur Radiol. 2000;10:569-572.

Smith E.R., McClain C.D., Heeney M., et al. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus. 2009;26:E10.

Smith E.R., Scott R.M. Surgical management of moyamoya syndrome. Skull Base. 2005;15:15-26.

Smith E.R., Scott R.M. Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus. 2008;24:E17.

Suzuki J., Takaku A. Cerebrovascular “moyamoya” disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288-299.

Veeravagu A., Guzman R., Patil C.G., et al. Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus. 2008;24:E16.

Numbered references appear on Expert Consult.

References

1. Suzuki J., Takaku A. Cerebrovascular “moyamoya” disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288-299.

2. Scott R.M., Smith E.R. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226-1237.

3. Isono M., Ishii K., Kobayashi H., et al. Effects of indirect bypass surgery for occlusive cerebrovascular diseases in adults. J Clin Neurosci. 2002;9:644-647.

4. Smith E.R., Scott R.M. Surgical management of moyamoya syndrome. Skull Base. 2005;15:15-26.

5. Veeravagu A., Guzman R., Patil C.G., et al. Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus. 2008;24:E16.

6. Ikezaki K. Rational approach to treatment of moyamoya disease in childhood. J Child Neurol. 2000;15:350-356.

7. Matsushima T., Inoue T., Ikezaki K., et al. Multiple combined indirect procedure for the surgical treatment of children with moyamoya disease. A comparison with single indirect anastomosis with direct anastomosis. Neurosurgical Focus. 1998. 5:e4

8. Matsushima T., Inoue T., Katsuta T., et al. An indirect revascularization method in the surgical treatment of moyamoya disease—various kinds of indirect procedures and a multiple combined indirect procedure. Neurol Med Chir (Tokyo). 1998;38(suppl):297-302.

9. Kawaguchi S., Okuno S., Sakaki T. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg. 2000;93:397-401.

10. Houkin K., Kamiyama H., Abe H., et al. Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke. 1996;27:1342-1346.

11. Sencer S., Poyanli A., Kiris T., et al. O. Recent experience with Moyamoya disease in Turkey. Eur Radiol. 2000;10:569-572.

12. Houkin K., Kuroda S., Nakayama N. Cerebral revascularization for moyamoya disease in children. Neurosurg Clin North Am. 2001;12:575-584. ix

13. Dauser R.C., Tuite G.F., McCluggage C.W. Dural inversion procedure for moyamoya disease. Technical note. J Neurosurg. 1997;86:719-723.

14. Scott R.M., Smith J.L., Roberstson R.L. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg Spine. 2004;100:142-149.

15. Smith E.R., McClain C.D., Heeney M., et al. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus. 2009;26:E10.

16. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (“moyamoya” disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99(suppl 2):S238-S240.

17. Fung L.W., Thompson D., Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005;21:358-364.

18. Smith E.R., Scott R.M. Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus. 2008;24:E17.

19. Scott R.M., Smith J.L., Robertson R.L., et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004;100:142-149.